ABSTRACT
We developed a 3.5-h-training for general practitioners (GPs) in delivering brief stop-smoking advice according to different methods (ABC, 5As). In a pragmatic, cluster randomised controlled trial our training proved effective in increasing GP-delivered rates of such advice. In this follow-up analysis we examined the effect of ABC and 5As on patient-reported quit attempts and point prevalence abstinence at weeks 4, 12, and 26 following GP consultation.
Follow-up data were collected by questionnaires delivered to 1,937 smoking patients recruited before or after the training in which 69 GPs participated. At week 26, ∼70% of the patients were lost to follow-up. All 1,937 smoking patients were included in an intention-to-treat analysis. Multiple imputation was used to impute missing outcome data of each follow-up and few missing data of potential confounders.
While the receipt of brief GP advice compared to no advice was associated with a two-fold increase in patients’ attempts to quit at each follow-up and abstinence at week 26, quit attempts and abstinence rates did not differ significantly from pre- to post-training or between patients from the ABC versus the 5As group.
We previously reported that our training increases patient-reported rates of GP-delivered stop-smoking advice. The present follow-up analysis did not show that patients more often attempted or achieved to quit when they received advice from a trained vs. untrained GP. Future training studies should take contextual factors into account – such as access to free evidence-based cessation treatment – which might hamper the transfer of GPs’ effective advice into patients’ behaviour change.
TRIAL REGISTRATION German Clinical Trials Register, prior to the first patient in (DRKS00012786, www.drks.de/drks_web/setLocale_EN.do).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
DRKS00012786, www.drks.de/drks_web/setLocale_EN.do
Funding Statement
The study was funded by the German Federal Ministry of Health (grant number ZMVI1-2516DSM221, Daniel Kotz). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the medical ethics committee at the Heinrich-Heine-University Duesseldorf, Germany (5999R).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying this study are third-party data (de-identified participant data) and are available to researchers on reasonable request from the corresponding author (sabrina.kastaun@med.uni-duesseldorf.de). All proposals requesting data access will need to specify how it is planned to use the data, and all proposals will need approval of the trial investigator team before data release. The study protocol [6], the statistical analysis plan (v3-3: https://osf.io/36kpc/) and statistical code (FU_rcode_v2-4: https://osf.io/5tfq7/) have been published.
Abbreviations
- 5As
- Ask, advice, assess, assist, arrange
- ABC
- Ask, brief advice, cessation support
- cRCT
- Cluster randomised controlled trial
- CI
- Confidence Interval
- COM-B
- Capability-Opportunity-Motivation-Behavior
- GP
- General practitioner
- NR
- Nicotine replacement therapy
- OR
- Odds Ratio
- SD
- Standard deviation
- SUTS
- Strength of Urges to Smoke Scale
